Effects of Qiliqiangxin capsule on patients with chronic pulmonary heart disease and heart failure

Objective To assess the effect of Qiliqiangxin capsule in combination with conventional treatment on patients with chronic pulmonary heart disease and heart failure.Methods 95 patients with chronic pulmonary heart disease and heart failure were randomly divided into two groups;observation group(48 cases),receiving conventional drug therapy plus Qiliqiangxin capsule 1.2g three times daily oral administration of 4 weeks;control group(47 cases),receiving only conventional drug treatment.The clinical improvement of symptoms and electrocardiogram,left ventricular ejection fraction(LVEF) and safety index before and after treatment were observed.Results Clinical evaluation;62.5%of markedly effective and 85.4%of total efficiency in observation group,53.2%of markedly effective and 74.5%of total efficiency in control group; ECG evaluation;54.2%of markedly effective and 81.2%of total efficiency in observation group,42.6%of markedly effective and 72.4%of total efficiency in control group;heart function were significantly improved in observation group and with no obvious adverse reactions.Conclusion For patients with chronic pulmonary heart disease and heart failure,Qiliqiangxin capsule with existing therapy is oi better improvement on symptoms and electrocardiogram,has better effect on improving left ventricular ejection fraction with no obvious side effects.,